- Home
- VATE vs ATRA Comparison
VATE vs ATRA Comparison
Compare VATE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- ATRA
- Stock Information
- Founded
- VATE 1994
- ATRA 2012
- Country
- VATE United States
- ATRA United States
- Employees
- VATE N/A
- ATRA N/A
- Industry
- VATE Metal Fabrications
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VATE Industrials
- ATRA Health Care
- Exchange
- VATE Nasdaq
- ATRA Nasdaq
- Market Cap
- VATE 63.4M
- ATRA 65.1M
- IPO Year
- VATE 1996
- ATRA 2014
- Fundamental
- Price
- VATE $5.11
- ATRA $6.57
- Analyst Decision
- VATE
- ATRA Buy
- Analyst Count
- VATE 0
- ATRA 6
- Target Price
- VATE N/A
- ATRA $25.70
- AVG Volume (30 Days)
- VATE 59.8K
- ATRA 306.8K
- Earning Date
- VATE 03-03-2025
- ATRA 11-12-2024
- Dividend Yield
- VATE N/A
- ATRA N/A
- EPS Growth
- VATE N/A
- ATRA N/A
- EPS
- VATE N/A
- ATRA N/A
- Revenue
- VATE $1,231,500,000.00
- ATRA $100,439,000.00
- Revenue This Year
- VATE N/A
- ATRA $1,339.87
- Revenue Next Year
- VATE N/A
- ATRA N/A
- P/E Ratio
- VATE N/A
- ATRA N/A
- Revenue Growth
- VATE N/A
- ATRA 2111.34
- 52 Week Low
- VATE $3.25
- ATRA $6.50
- 52 Week High
- VATE $10.80
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- VATE 47.68
- ATRA 32.06
- Support Level
- VATE $4.72
- ATRA $6.55
- Resistance Level
- VATE $5.77
- ATRA $17.83
- Average True Range (ATR)
- VATE 0.37
- ATRA 2.21
- MACD
- VATE -0.04
- ATRA -0.91
- Stochastic Oscillator
- VATE 35.78
- ATRA 0.16
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).